European Companies Search Engine
EU funding (€50,000): Enabling high performance and cost-efficient Point-of-Care diagnostics using a new innovative synthetic lateral flow substrate Hor1 Feb 2019 EU Research and Innovation programme "Horizon"
Overview
Text
Enabling high performance and cost-efficient Point-of-Care diagnostics using a new innovative synthetic lateral flow substrate
Mercene Labs is a Swedish SME with expertise in material design for adhesion and surface control developing products that benefit quality of life worldwide through creating unique solutions based on our proprietary Ostemer™ polymer platform. Our newest product Synthetic Paper comes from an urgent industry need to increase the performance of point-of-care (PoC) medical diagnostic tests by finding better alternatives to the traditional paper-based lateral flow products currently in use. Improvements in the performance of lateral flow assays could lead to more rapid clinical decision making and timely interventions with appropriate treatments as well as more personalized healthcare benefiting millions of patients worldwide. Synthetic Paper provides superior material properties in terms of repeatability in geometry and surface energy while being able to directly replace nitrocellulose strips in current readers while utilizing the existing POC readers and infrastructure. Currently Mercene Labs is able to provide Synthetic Paper in A4 sheets with a native (untreated) surface, as well as surfaces modified for specific liquid flow speed. However, manufacturers of PoC tests are used to purchasing test strip material that is ready for antibody bonding. The feasibility study, performed under this SME Phase 1 project, will focus adding to the product offering by modifying the surface to offer customers a higher value product. Additionally, the feasibility study will focus on developing a pricing strategy and a business model for Synthetic paper.
Funded Companies:
| Company name | Funding amount |
| Mercene Labs AB | €50,000 |
Source: https://cordis.europa.eu/project/id/855892
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Mercene Labs AB, Stockholm, Sweden.
The visualizations for "Mercene Labs AB - EU funding (€50,000): Enabling high performance and cost-efficient Point-of-Care diagnostics using a new innovative synthetic lateral flow substrate"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
